ENDRA Life Sciences Inc.

NASDAQ (USD): ENDRA Life Sciences Inc. (NDRA)

Last Price

5.51

Today's Change

+0.14 (2.60%)

Day's Change

5.17 - 6.30

Trading Volume

53,052

Overview

Market Cap

2 Million

Shares Outstanding

536,908

Avg Volume

266,402

Avg Price (50 Days)

6.73

Avg Price (200 Days)

301.56

PE Ratio

-0.05

EPS

-105.78

Earnings Announcement

27-Mar-2025

Previous Close

5.37

Open

5.29

Day's Range

5.17 - 6.3

Year Range

4.01 - 4663.75

Trading Volume

52,751

Price Change Highlight

1 Day Change

2.61%

5 Day Change

18.49%

1 Month Change

4.55%

3 Month Change

-20.14%

6 Month Change

-97.42%

Ytd Change

-99.80%

1 Year Change

-99.86%

3 Year Change

-99.98%

5 Year Change

-99.99%

10 Year Change

-100.00%

Max Change

-100.00%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Diagnostics & Research

Description:

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment